Figure 2.
Right lower lobe nodule, NSCLC. (A) Pre-treatment contrast-enhanced; (B) contrast-enhanced CT 6 weeks later after treatment, the efficacy evaluation was partial response (PR); (C) kurtosis; (D) S(1,0) SumEntrp map; (E) S(2,2) SumEntrp map.